All Stories

  1. “Nothing burns like the cold”: Cardiovascular disease in frigid zones
  2. Extracellular Vesicles as Theranostic Tools in Kidney Disease
  3. Senomorphic, senolytic, and rejuvenation therapies
  4. Stem Cells to the Rescue: Development and Application of Cell-Based Therapy for Microvascular Repair
  5. Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy
  6. Reply
  7. A modified two-compartment model for measurement of renal function using dynamic contrast-enhanced computed tomography
  8. Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men
  9. Metabolic Syndrome Induces Release of Smaller Extracellular Vesicles from Porcine Mesenchymal Stem Cells
  10. Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men
  11. Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease
  12. Coronary Microvasculature
  13. Micro-RNAS Regulate Metabolic Syndrome-induced Senescence in Porcine Adipose Tissue-derived Mesenchymal Stem Cells through the P16/MAPK Pathway
  14. TCT-402 Serum uric acid levels predict longterm adverse cardiovascular outcomes after cardiac transplantation
  15. Ubiquitous yet unseen: microvascular endothelial dysfunction beyond the heart
  16. Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine
  17. The Rho(ad)-kinase for individualized treatment of vasospastic angina
  18. Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair
  19. Cardiorenal biomarkers: one step closer
  20. Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension
  21. Investigating the Metabolic Syndrome
  22. Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease
  23. Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension
  24. Mitochondria
  25. Adipose tissue remodeling in a novel domestic porcine model of diet-induced obesity
  26. Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease
  27. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage
  28. Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses
  29. Assessment of Renal Artery Stenosis Using Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging Analysis
  30. Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women
  31. Mesenchymal stem cell treatment for chronic renal failure
  32. Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease
  33. Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension
  34. PREDICTIVE VALUE OF ENDOTHELIAL FUNCTION BY NON-INVASIVE PERIPHERAL ARTERIAL TONOMETRY FOR CORONARY ARTERY DISEASE
  35. THE AUGMENTATION OF USUAL CARDIAC REHABILITATION WITH AN ONLINE AND SMARTPHONE-BASED PROGRAM IMPROVES CARDIOVASCULAR RISK FACTORS AND REDUCES REHOSPITALIZATIONS
  36. ISCHEMIC CARDIOMYOPATHY IS ASSOCIATED WITH PLAQUE PROGRESSION AND HIGHER EVENT RATE IN PATIENTS POST-CARDIAC TRANSPLANTATION
  37. BOLD assessment—effects of RAAS inhibition in CKD
  38. Reality and Renovascular Disease: When Does Renal Artery Stenosis Warrant Revascularization?
  39. Using an online, personalized program reduces cardiovascular risk factor profiles in a motivated, adherent population of participants
  40. Renal Vascular Disease
  41. Future Mechanisms of Reversing Kidney Injury
  42. Coronary endothelial function in patients with obstructive sleep apnea
  43. Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension
  44. Renal Relevant Radiology: Renal Functional Magnetic Resonance Imaging
  45. TCT-607 Sex-related differences in fractional flow reserve guided treatment
  46. Redox Signaling Is an Early Event in the Pathogenesis of Renovascular Hypertension
  47. Concise review: Mesenchymal stem cell treatment for ischemic kidney disease
  48. Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis
  49. Renal Artery Stenosis: Medical Versus Interventional Therapy
  50. Primary proteasome inhibition results in cardiac dysfunction
  51. Osteopontin: an emerging therapeutic target in uraemic vascular disease
  52. Renin inhibition with aliskiren lowers circulating endothelial progenitor cells in patients with early atherosclerosis
  53. Improved Renal Revascularization Outcomes in Pigs Using Stem Cells
  54. Endothelial Dysfunction Occurs prior to Clinical Evidence of Polycystic Kidney Disease
  55. High Leukocyte Count Is Associated With Peripheral Vascular Dysfunction in Individuals With Low Cardiovascular Risk
  56. TGF Expression and Macrophage Accumulation in Atherosclerotic Renal Artery Stenosis
  57. Mesenchymal Stem Cells and Endothelial Progenitor Cells Decrease Renal Injury in Experimental Swine Renal Artery Stenosis Through Different Mechanisms
  58. Role of Circulating Osteogenic Progenitor Cells in Calcific Aortic Stenosis
  59. Comparison of the Effect of the Metabolic Syndrome and Multiple Traditional Cardiovascular Risk Factors on Vascular Function
  60. Humanin prevents intra-renal microvascular remodeling and inflammation in hypercholesterolemic ApoE deficient mice
  61. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems
  62. Impaired myocardial autophagy linked to energy metabolism disorders
  63. Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis
  64. Compartmental Analysis of Renal BOLD MRI Data
  65. OSTEOCALCIN POSITIVE CD133+/CD34-/KDR+ PROGENITOR CELLS AS MARKERS OF CORONARY ARTERY DISEASE AND PROGNOSIS
  66. THE IMMUNOPROTEASOME – A NEW CHARACTERISTIC OF SYMPTOMATIC CAROTID ARTERY PLAQUES
  67. OSTEOCALCIN POSITIVE CD133+/CD34-/KDR+ PROGENITOR CELLS ARE ASSOCIATED WITH POOR GLYCEMIC CONTROL
  68. Inflammatory Cell Markers as Indicators of Atherosclerotic Renovascular Disease
  69. Personalized Medicine in Cardiovascular Diseases
  70. Novel Functional Risk Factors for the Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
  71. Cell-Based Therapies as an Adjunct to Revascularization in Experimental Atherosclerotic Reno Vascular Disease
  72. Normal Vascular Function as a Prerequisite for the Absence of Coronary Calcification in Patients Free of Cardiovascular Disease and Diabetes
  73. The Association Between Renal Atherosclerotic Plaque Characteristics and Renal Function Before and After Renal Artery Intervention
  74. Blood Oxygen Level–Dependent (BOLD) MRI in Renovascular Hypertension
  75. Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect
  76. The Metabolic Syndrome and Early Kidney Disease: Another Link in the Chain?
  77. El síndrome metabólico y la enfermedad renal temprana: ¿un eslabón más de la cadena?
  78. DIAGNOSIS AND TREATMENT OF MICROVASCULAR ENDOTHELIAL DYSFUNCTION LEADS TO IMPROVED QUALITY OF LIFE.
  79. Imaging of Transplanted and Native Stem Cells
  80. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: Role of oxidative stress
  81. Renovascular Hypertension and Ischemic Nephropathy
  82. Endothelial function as a functional expression of cardiovascular risk factors
  83. Endothelial Progenitor Cells Homing and Renal Repair in Experimental Renovascular Disease
  84. LONG TERM ENDOTHELIN RECEPTOR ANTAGONIST IMPROVES CORONARY ENDOTHELIAL FUNCTION IN PATIENTS WITH EARLY ATHEROSCLEROSIS
  85. Nitric Oxide in Vascular Damage and Regeneration
  86. Mechanisms of Tissue Injury in Renal Artery Stenosis: Ischemia and Beyond
  87. Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy
  88. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension
  89. The Uncertain Value of Renal Artery Interventions
  90. Association of Plaque Composition and Vessel Remodeling in Atherosclerotic Renal Artery Stenosis
  91. Angiogenesis in the kidney: a new therapeutic target?
  92. Phase‐contrast MRI‐based elastography technique detects early hypertensive changes in ex vivo porcine aortic wall
  93. Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation
  94. Sex differences in vascular and endothelial responses to acute mental stress
  95. Reply
  96. Simvastatin abates development of renal fibrosis in experimental renovascular disease
  97. Role of lipoprotein-associated phospholipase A2 in atherosclerosis
  98. Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis
  99. Association Between the Paraoxonase-1 192Q>R Allelic Variant and Coronary Endothelial Dysfunction in Patients With Early Coronary Artery Disease
  100. Association Between the Paraoxonase-1 192Q>R Allelic Variant and Coronary Endothelial Dysfunction in Patients With Early Coronary Artery Disease
  101. New Frontiers in the Evaluation of Cardiac Patients for Noncardiac Surgery
  102. Frontiers in Nephrology
  103. Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia
  104. Vulnerable Plaque: Detection and Management
  105. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia—Implications for vulnerable plaque-development
  106. Relation of Depression to Coronary Endothelial Function
  107. Assessment of Myocardial Microvascular Function: New Opportunities in Fast Computed Tomography
  108. Atherosclerotic process, renovascular disease and outcomes from bench to bedside
  109. Dietary reversal of experimental hypercholesterolemia improves endothelial dysfunction of epicardial arteries but not of small coronary vessels in pigs
  110. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia
  111. Review – 3D Micro CT Imaging of Renal Micro-Structural Changes
  112. Bosentan preserves endothelial function in mice overexpressing APP
  113. Positron emission tomography imaging of the kidneys
  114. Renal Artery Disease: Pathophysiology
  115. Plasma 8-iso-prostaglandin F2α, a marker of oxidative stress, is increased in patients with acute myocardial infarction
  116. Animal models of hypertension: An overview
  117. Kidney in Early Atherosclerosis
  118. The ubiquitin‐proteasome system—micro target for macro intervention?
  119. Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries
  120. Adventitial vasa vasorum heterogeneity among different vascular beds
  121. 1027-189 Chronic endothelin receptor antagonism preserves endothelial function in a transgenic mouse model of alzheimer's disease
  122. Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia
  123. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis
  124. Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia
  125. New insights in the transcriptional activity and coregulator molecules in the arterial wall
  126. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
  127. Quantification of Myocardial Microcirculatory Function with X‐ray CT
  128. Renal Handling of X‐ray Contrast Media Imaging and Exploration with Electron Beam CT
  129. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering
  130. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering
  131. Simvastatin preserves myocardial perfusion and permeability in experimental hypercholesterolemia independent of lipid lowering
  132. Chronic selective endothelin a receptor antagonism preserves myocardial perfusion in experimental hypercholesterolemia
  133. Enhanced renal cortical vascularization in experimental hypercholesterolemia
  134. Oxidation-Sensitive Transcription Factors and Molecular Mechanisms in the Arterial Wall
  135. Pathophysiology of ischemic nephropathy
  136. Coronary Microvascular Functional Reserve: Quantification of Long-term Changes with Electron-Beam CT—Preliminary Results in a Porcine Model1
  137. Involvement of Oxidation-Sensitive Mechanisms in the Cardiovascular Effects of Hypercholesterolemia
  138. Involvement of Oxidation-Sensitive Mechanisms in the Cardiovascular Effects of Hypercholesterolemia
  139. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity
  140. Cardiac Production of Angiotensin II and Its Pharmacologic Inhibition: Effects on the Coronary Circulation
  141. Cardiac Production of Angiotensin II and Its Pharmacologic Inhibition: Effects on the Coronary Circulation
  142. Measurement of In Vivo Myocardial Microcirculatory Function with Electron Beam CT
  143. The development of x-ray imaging to study renal function
  144. Renal tubular dynamics in the intact canine kidney
  145. Reproducibility of Human Kidney Perfusion and Volume Determinations with Electron Beam Computed Tomography
  146. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension
  147. Quantitation of the In Vivo Kidney Volume with Cine Computed Tomography